Profile of Ofatumumab in the Treatment of Multiple Sclerosis: Design, Development and Place in Therapy
Introduction Multiple sclerosis (MS) is an autoimmune pathology characterized by demyelination within the central nervous system (CNS) encompasses inflammatory and neurodegenerative processes. Approximately 2.8 million individuals worldwide are affected by …